image: Macrophages taking up the siRNA-loaded nanoparticles (red) harboring different versions of the cell-binding S2P peptide. This material relates to a paper that appeared in the Jul. 22, 2020, issue of Science Translational Medicine, published by AAAS. The paper, by W. Tao at Brigham and Women's Hospital in Boston, MA; and colleagues was titled, "siRNA nanoparticles targeting CaMKIIγ in lesional macrophages improve atherosclerotic plaque stability in mice." view more
Credit: [Credit: W. Tao <i>et al., Science Translational Medicine</i> (2020)]